In Vivo Screening for Secreted Proteins That Modulate Glucose Handling Identifies Interleukin-6 Family Members as Potent Hypoglycemic Agents
Authors:
Open Access
- 4 September 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (9) , e44600
Abstract
Diabetes is a disease of abnormal glucose homeostasis characterized by chronic hyperglycemia and a broad array of consequent organ damage. Because normal glucose homeostasis is maintained by a complex interaction between behavior (feeding and physical activity) and metabolic activity that is modulated by inter-organ signaling through secreted factors, disease modeling in vitro is necessarily limited. In contrast, in vivo studies allow complex metabolic phenotypes to be studied but present a barrier to high throughput studies. Here we present the development of a novel in vivo screening platform that addresses this primary limitation of in vivo experimentation. Our platform leverages the large secretory capacity of the liver and the hepatocyte transfection technique of hydrodynamic tail vein injection to achieve supraphysiologic blood levels of secreted proteins. To date, the utility of hydrodynamic transfection has been limited by the deleterious impact of the variable transfection efficiency inherent to this technique. We overcome this constraint by co-transfection of a secreted luciferase cDNA whose product can be easily monitored in the blood of a living animal and used as a surrogate marker for transfection efficiency and gene expression levels. To demonstrate the utility of our strategy, we screened 248 secreted proteins for the ability to enhance glucose tolerance. Surprisingly, interleukin-6 and several of its family members but not other well-recognized insulin sensitizing agents were identified as potent hypoglycemic factors. We propose this experimental system as a powerful and flexible in vivo screening platform for identifying genes that modulate complex behavioral and metabolic phenotypes.Keywords
This publication has 50 references indexed in Scilit:
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Duration of Expression and Activity of Sleeping Beauty Transposase in mouse liver following hydrodynamic DNA deliveryMolecular Therapy, 2010
- Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivoNature Protocols, 2009
- Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injectionNature Protocols, 2007
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005
- Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar–Kyoto ratsGene Therapy, 2003
- Leptin selectively decreases visceral adiposity and enhances insulin action.Journal of Clinical Investigation, 1997
- Effect of chronic IL-1β infusion on glucose homeostasis and pancreatic insulin secretionLife Sciences, 1994